Quince Therapeutics (QNCX)

• Market cap: $223M
• 1 day: 11.39%
• 5 days: 11.39%
• 1 month: 153.8%
• 3 months: 149.07%
• 6 months: 236.97%
• Year to date: 113.3%
• 1 year: 120.33%
• 5 years: -90.02%
• 10 years: -87.81%
• Sector: Healthcare
• Industry: Biotechnology

About: Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Employees: 36